These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 6304818

  • 1. Synthetic leukotriene B4 is a potent chemotaxin but a weak secretagogue for human PMN.
    Rollins TE, Zanolari B, Springer MS, Guindon Y, Zamboni R, Lau CK, Rokach J.
    Prostaglandins; 1983 Feb; 25(2):281-9. PubMed ID: 6304818
    [Abstract] [Full Text] [Related]

  • 2. A reevaluation of the chemotactic potency of leukotriene B4 (LTB4).
    Jubiz W.
    Biochem Biophys Res Commun; 1983 Feb 10; 110(3):842-50. PubMed ID: 6301465
    [Abstract] [Full Text] [Related]

  • 3. Human monocyte and polymorphonuclear leukocyte chemotactic and chemokinetic responses to leukotriene B4 and FMLP.
    Ternowitz T, Herlin T, Fogh K.
    Acta Pathol Microbiol Immunol Scand C; 1987 Apr 10; 95(2):47-54. PubMed ID: 3037849
    [Abstract] [Full Text] [Related]

  • 4. Wheat germ agglutinin specifically inhibits formyl peptide-induced polymorphonuclear leukocyte chemotaxis.
    Perez HD, Ong R, Khanna K, Banda D, Goldstein IM.
    J Immunol; 1982 Dec 10; 129(6):2718-24. PubMed ID: 6897258
    [Abstract] [Full Text] [Related]

  • 5. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
    Fletcher MP.
    J Immunol; 1986 Jun 01; 136(11):4213-9. PubMed ID: 3009618
    [Abstract] [Full Text] [Related]

  • 6. Effect of 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-prostaglandin 1(1) (U-60,257), an inhibitor of leukotriene synthesis, on human neutrophil function.
    Smith RJ, Sun FF, Bowman BJ, Iden SS, Smith HW, McGuire JC.
    Biochem Biophys Res Commun; 1982 Dec 15; 109(3):943-9. PubMed ID: 6297495
    [No Abstract] [Full Text] [Related]

  • 7. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.
    Kurrasch R, Elfman F, Perez HD.
    J Immunol; 1989 Sep 15; 143(6):1969-73. PubMed ID: 2550548
    [Abstract] [Full Text] [Related]

  • 8. Leukotriene B4 is a complete secretagogue in human neutrophils: a kinetic analysis.
    Serhan CN, Radin A, Smolen JE, Korchak H, Samuelsson B, Weissmann G.
    Biochem Biophys Res Commun; 1982 Aug 15; 107(3):1006-12. PubMed ID: 6291511
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils.
    Ham EA, Soderman DD, Zanetti ME, Dougherty HW, McCauley E, Kuehl FA.
    Proc Natl Acad Sci U S A; 1983 Jul 15; 80(14):4349-53. PubMed ID: 6308617
    [Abstract] [Full Text] [Related]

  • 10. Effects of novel lipoxygenase products on neutrophil and eosinophil functions in vitro.
    Palmblad J, Udén AM, Friberg I, Ringertz B, Rådmark O, Lindgren JA, Hansson G, Malmsten CL.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Jul 15; 12():25-31. PubMed ID: 6303087
    [No Abstract] [Full Text] [Related]

  • 11. Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation.
    Preissner WC, Schröder JM, Christophers E.
    Br J Dermatol; 1983 Jul 15; 109(1):1-8. PubMed ID: 6860565
    [Abstract] [Full Text] [Related]

  • 12. Release of leukotriene B4 from human neutrophils and its relationship to degranulation induced by N-formyl-methionyl-leucyl-phenylalanine, serum-treated zymosan and the ionophore A23187.
    Palmer RM, Salmon JA.
    Immunology; 1983 Sep 15; 50(1):65-73. PubMed ID: 6309653
    [Abstract] [Full Text] [Related]

  • 13. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins.
    Morita E, Schröder JM, Christophers E.
    Scand J Immunol; 1989 Jun 15; 29(6):709-16. PubMed ID: 2544988
    [Abstract] [Full Text] [Related]

  • 14. Fibrin regulates neutrophil migration in response to interleukin 8, leukotriene B4, tumor necrosis factor, and formyl-methionyl-leucyl-phenylalanine.
    Loike JD, el Khoury J, Cao L, Richards CP, Rascoff H, Mandeville JT, Maxfield FR, Silverstein SC.
    J Exp Med; 1995 May 01; 181(5):1763-72. PubMed ID: 7722453
    [Abstract] [Full Text] [Related]

  • 15. Stimulation of human polymorphonuclear leukocytes by leukotriene B4 and platelet-activating factor: an ultrastructural and pharmacological study.
    Rossi AG, MacIntyre DE, Jones CJ, McMillan RM.
    J Leukoc Biol; 1993 Feb 01; 53(2):117-25. PubMed ID: 8383164
    [Abstract] [Full Text] [Related]

  • 16. Specific binding of leukotriene B4 to a receptor on human polymorphonuclear leukocytes.
    Kreisle RA, Parker CW.
    J Exp Med; 1983 Feb 01; 157(2):628-41. PubMed ID: 6296265
    [Abstract] [Full Text] [Related]

  • 17. Chemotaxis of horse polymorphonuclear leukocytes to N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
    Zinkl JG, Brown PD.
    Am J Vet Res; 1982 Apr 01; 43(4):613-6. PubMed ID: 7073083
    [Abstract] [Full Text] [Related]

  • 18. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW, Enkel H, Gifford LA, Chenoweth DE, Rosenbaum JT.
    J Immunol; 1986 Sep 15; 137(6):1971-6. PubMed ID: 3018083
    [Abstract] [Full Text] [Related]

  • 19. 15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils.
    Ternowitz T, Fogh K, Kragballe K.
    Skin Pharmacol; 1988 Sep 15; 1(2):93-9. PubMed ID: 2856182
    [Abstract] [Full Text] [Related]

  • 20. Depressed leukotriene B4 chemotactic response of neutrophils from localized juvenile periodontitis patients.
    Offenbacher S, Scott SS, Odle BM, Wilson-Burrows C, Van Dyke TE.
    J Periodontol; 1987 Sep 15; 58(9):602-6. PubMed ID: 2821216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.